Your browser doesn't support javascript.
loading
Genetic and pharmacological inhibition of METTL3 alleviates renal fibrosis by reducing EVL m6A modification through an IGF2BP2-dependent mechanism.
Ni, Wei-Jian; Zhou, Hong; Lu, Hao; Ma, Nan-Nan; Hou, Bing-Bing; Li, Wei; Kong, Fan-Xu; Yu, Ju-Tao; Hou, Rui; Jin, Juan; Wen, Jia-Gen; Zhang, Tao; Meng, Xiao-Ming.
Affiliation
  • Ni WJ; Department of Pharmacy, Anhui Provincial Hospital, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, People's Republic of China.
  • Zhou H; Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei, Anhui, People's Republic of China.
  • Lu H; Department of Pharmacy, Anhui Provincial Cancer Hospital, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, People's Republic of China.
  • Ma NN; Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei, Anhui, People's Republic of China.
  • Hou BB; Department of Urology, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, People's Republic of China.
  • Li W; Department of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, People's Republic of China.
  • Kong FX; Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei, Anhui, People's Republic of China.
  • Yu JT; Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei, Anhui, People's Republic of China.
  • Hou R; Department of Pharmacy, The Second People's Hospital of Hefei, Hefei, Anhui, People's Republic of China.
  • Jin J; Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei, Anhui, People's Republic of China.
  • Wen JG; Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei, Anhui, People's Republic of China.
  • Zhang T; Research Center for Translational Medicine, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, People's Republic of China.
  • Meng XM; School of Basic Medicine, Anhui Medical University, Hefei, Anhui, People's Republic of China.
Clin Transl Med ; 13(8): e1359, 2023 08.
Article in En | MEDLINE | ID: mdl-37537731
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: RNA / Methyltransferases Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Clin Transl Med Year: 2023 Document type: Article Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: RNA / Methyltransferases Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Clin Transl Med Year: 2023 Document type: Article Country of publication: Estados Unidos